Paris, France

Christophe Delenda

USPTO Granted Patents = 2 


 

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2013-2016

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Christophe Delenda

Introduction

Christophe Delenda, a notable inventor based in Paris, France, has made significant contributions to the field of genetic engineering. With two patents to his name, he is particularly known for his innovative work at the company Cellectis. His research focuses on developing advanced genetic constructs that enable targeted genomic modifications.

Latest Patents

Christophe Delenda's latest patent is centered on the Meganuclease recombination system. This invention encompasses a set of genetic constructs that facilitate the efficient and reproducible introduction of a specific nucleotide sequence at a predetermined position within the genome. By utilizing a meganuclease to generate a double strand break at a targeted location, his invention stimulates a homologous recombination event between the genomic site and a transfected donor sequence. Additionally, this patent includes methods utilizing these constructs and offers them in the form of a kit for broader application.

Career Highlights

Delenda's work at Cellectis, a pioneering company in genome editing, has positioned him as a key player in the field. His patents not only highlight his ingenuity but also reflect the company's commitment to exploring innovative solutions in genetic modification. His expertise is greatly valued in advancing therapeutic approaches to various genetic conditions.

Collaborations

Throughout his career, Christophe Delenda has collaborated with prominent scientists in the field, including Jean-Pierre Cabaniols and Andre Choulika. Working alongside these esteemed colleagues has enriched his research and contributed to the innovative spirit at Cellectis.

Conclusion

Christophe Delenda stands out as an inventive leader in genetic engineering. With two patents, his contributions through the Meganuclease recombination system are poised to influence the future of genome editing. His ongoing work at Cellectis continues to push the boundaries of scientific discovery, showcasing the impactful role of inventors in advancing technology and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…